The immunological functions of saposins

Advances in Immunology

Volumn 105, Issue C, 2010, Pages 25-62

  Darmoise, Alexandre ^a   Maschmeyer, Patrick ^a   Winau, Florian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; GANGLIOSIDE GM2 ACTIVATOR PROTEIN; GLYCOPROTEIN; HYDROLASE; SAPOSIN A; SAPOSIN B; SAPOSIN C; SAPOSIN D; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; UNCLASSIFIED DRUG; CD1D ANTIGEN; GLUCOSYLCERAMIDASE;

ANTIGEN PRESENTATION; ARTICLE; BILAYER MEMBRANE; BINDING AFFINITY; ENZYME BINDING; HUMAN; LIPID DEGRADATION; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; LYSOSOME; LYSOSOME MEMBRANE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTON TRANSPORT; T LYMPHOCYTE; CHEMISTRY; ENDOSOME; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER T CELL; REVIEW;

ANTIGEN PRESENTATION; ANTIGENS, CD1D; ENDOSOMES; GLUCOSYLCERAMIDASE; GLYCOPROTEINS; LIPID METABOLISM; LYMPHOCYTE ACTIVATION; LYSOSOMES; NATURAL KILLER T-CELLS; SAPOSINS; SPHINGOLIPIDS;

EID: 77955975049     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(10)05002-9     Document Type: Chapter

References (205)

1. Ahn V.E., Faull K.F., Whitelegge J.P., Fluharty A.L., Prive G.G. Crystal structure of saposin B reveals a dimeric shell for lipid binding. Proc. Natl. Acad. Sci. USA 2003, 100:38-43.
2. Ahn V.E., Leyko P., Alattia J.R., Chen L., Prive G.G. Crystal structures of saposins A and C. Protein Sci. 2006, 15:1849-1857.
3. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998, 188:1359-1368.
4. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
5. Albert M.L., Jegathesan M., Darnell R.B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2001, 2:1010-1017.
6. Anderson D.H., Sawaya M.R., Cascio D., Ernst W., Modlin R., Krensky A., Eisenberg D. Granulysin crystal structure and a structure-derived lytic mechanism. J. Mol. Biol. 2003, 325:355-365.
7. Andersson M., Gunne H., Agerberth B., Boman A., Bergman T., Sillard R., Jornvall H., Mutt V., Olsson B., Wigzell H., et al. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 1995, 14:1615-1625.
8. Andra J., Leippe M. Pore-forming peptide of Entamoeba histolytica. Significance of positively charged amino acid residues for its mode of action. FEBS Lett. 1994, 354:97-102.
9. Andre P., Perlemuter G., Budkowska A., Brechot C., Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin. Liver Dis. 2005, 25:93-104.
10. Angenieux C., Fraisier V., Maitre B., Racine V., van der Wel N., Fricker D., Proamer F., Sachse M., Cazenave J.P., Peters P., et al. The cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 2005, 6:286-302.
11. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., Brenner M.B. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994, 372:691-694.
12. Beckman E.M., Melian A., Behar S.M., Sieling P.A., Chatterjee D., Furlong S.T., Matsumoto R., Rosat J.P., Modlin R.L., Porcelli S.A. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 1996, 157:2795-2803.
13. Bendelac A., Lantz O., Quimby M.E., Yewdell J.W., Bennink J.R., Brutkiewicz R.R. CD1 recognition by mouse NK1+ T lymphocytes. Science 1995, 268:863-865.
14. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
15. Berent S.L., Radin N.S. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). Biochim. Biophys. Acta 1981, 664:572-582.
16. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 1976, 143:1283-1288.
17. Bracha R., Nuchamowitz Y., Mirelman D. Transcriptional silencing of an amoebapore gene in Entamoeba histolytica: Molecular analysis and effect on pathogenicity. Eukaryot. Cell 2003, 2:295-305.
18. Bradova V., Smid F., Ulrich-Bott B., Roggendorf W., Paton B.C., Harzer K. Prosaposin deficiency: Further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum. Genet. 1993, 92:143-152.
19. Brigl M., Brenner M.B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 2004, 22:817-890.
20. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003, 4:1230-1237.
21. Briken V., Jackman R.M., Watts G.F., Rogers R.A., Porcelli S.A. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J. Exp. Med. 2000, 192:281-288.
22. Bruhn H. A short guided tour through functional and structural features of saposin-like proteins. Biochem. J. 2005, 389:249-257.
23. Budd R.C., Miescher G.C., Howe R.C., Lees R.K., Bron C., MacDonald H.R. Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J. Exp. Med. 1987, 166:577-582.
24. Chen Y.H., Chiu N.M., Mandal M., Wang N., Wang C.R. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 1997, 6:459-467.
25. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H., Dautry-Varsat A., Bendelac A. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 1999, 189:103-110.
26. Chiu Y.H., Park S.H., Benlagha K., Forestier C., Jayawardena-Wolf J., Savage P.B., Teyton L., Bendelac A. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 2002, 3:55-60.
27. Christiansen D., Milland J., Mouhtouris E., Vaughan H., Pellicci D.G., McConville M.J., Godfrey D.I., Sandrin M.S. Humans lack iGb3 due to the absence of functional iGb3-synthase: Implications for NKT cell development and transplantation. PLoS Biol. 2008, 6:e172.
28. Christomanou H., Chabas A., Pampols T., Guardiola A. Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder. Klin. Wochenschr. 1989, 67:999-1003.
29. Chu Z., Witte D.P., Qi X. Saposin C-LBPA interaction in late-endosomes/lysosomes. Exp. Cell Res. 2005, 303:300-307.
30. Ciaffoni F., Salvioli R., Tatti M., Arancia G., Crateri P., Vaccaro A.M. Saposin D solubilizes anionic phospholipid-containing membranes. J. Biol. Chem. 2001, 276:31583-31589.
31. Ciaffoni F., Tatti M., Salvioli R., Vaccaro A.M. Interaction of saposin D with membranes: Effect of anionic phospholipids and sphingolipids. Biochem. J. 2003, 373:785-792.
32. Ciaffoni F., Tatti M., Boe A., Salvioli R., Fluharty A., Sonnino S., Vaccaro A.M. Saposin B binds and transfers phospholipids. J. Lipid Res. 2006, 47:1045-1053.
33. Conzelmann E., Sandhoff K. AB variant of infantile GM2 gangliosidosis: Deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc. Natl. Acad. Sci. USA 1978, 75:3979-3983.
34. Conzelmann E., Sandhoff K. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Hoppe Seylers Z. Physiol. Chem. 1979, 360:1837-1849.
35. Conzelmann E., Burg J., Stephan G., Sandhoff K. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. Eur. J. Biochem. 1982, 123:455-464.
36. D'Andrea A., Goux D., De Lalla C., Koezuka Y., Montagna D., Moretta A., Dellabona P., Casorati G., Abrignani S. Neonatal invariant Valpha24+ NKT lymphocytes are activated memory cells. Eur. J. Immunol. 2000, 30:1544-1550.
37. de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.F., Malm D., Berg T., Paoletti S., Maitre B., Mourey L., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005, 310:1321-1324.
38. De Libero G., Moran A.P., Gober H.J., Rossy E., Shamshiev A., Chelnokova O., Mazorra Z., Vendetti S., Sacchi A., Prendergast M.M., et al. Bacterial infections promote T cell recognition of self-glycolipids. Immunity 2005, 22:763-772.
39. Degen E., Cohen-Doyle M.F., Williams D.B. Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide. J. Exp. Med. 1992, 175:1653-1661.
40. Delia D., Cattoretti G., Polli N., Fontanella E., Aiello A., Giardini R., Rilke F., Della Porta G. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: Identification of a new B-cell subset. Blood 1988, 72:241-247.
41. Dellabona P., Padovan E., Casorati G., Brockhaus M., Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 1994, 180:1171-1176.
42. Dougan S.K., Salas A., Rava P., Agyemang A., Kaser A., Morrison J., Khurana A., Kronenberg M., Johnson C., Exley M., et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J. Exp. Med. 2005, 202:529-539.
43. Dougan S.K., Kaser A., Blumberg R.S. CD1 expression on antigen-presenting cells. Curr. Top. Microbiol. Immunol. 2007, 314:113-141.
44. Dougan S.K., Rava P., Hussain M.M., Blumberg R.S. MTP regulated by an alternate promoter is essential for NKT cell development. J. Exp. Med. 2007, 204:533-545.
45. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., Park D., Woodson R.I., Ostankovich M., Sharma P., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
46. Ernst W.A., Maher J., Cho S., Niazi K.R., Chatterjee D., Moody D.B., Besra G.S., Watanabe Y., Jensen P.E., Porcelli S.A., et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 1998, 8:331-340.
47. Ernst W.A., Thoma-Uszynski S., Teitelbaum R., Ko C., Hanson D.A., Clayberger C., Krensky A.M., Leippe M., Bloom B.R., Ganz T., et al. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 2000, 165:7102-7108.
48. Exley M., Garcia J., Wilson S.B., Spada F., Gerdes D., Tahir S.M., Patton K.T., Blumberg R.S., Porcelli S., Chott A., et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000, 100:37-47.
49. Fischer K., Scotet E., Niemeyer M., Koebernick H., Zerrahn J., Maillet S., Hurwitz R., Kursar M., Bonneville M., Kaufmann S.H., et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 2004, 101:10685-10690.
50. Fowlkes B.J., Kruisbeek A.M., Ton-That H., Weston M.A., Coligan J.E., Schwartz R.H., Pardoll D.M. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature 1987, 329:251-254.
51. Friedland N., Liou H.L., Lobel P., Stock A.M. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc. Natl. Acad. Sci. USA 2003, 100:2512-2517.
52. Fujita N., Suzuki K., Vanier M.T., Popko B., Maeda N., Klein A., Henseler M., Sandhoff K., Nakayasu H. Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet. 1996, 5:711-725.
53. Furst W., Sandhoff K. Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta 1992, 1126:1-16.
54. Furst W., Machleidt W., Sandhoff K. The precursor of sulfatide activator protein is processed to three different proteins. Biol. Chem. Hoppe Seyler 1988, 369:317-328.
55. Futter C.E., Pearse A., Hewlett L.J., Hopkins C.R. Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J. Cell Biol. 1996, 132:1011-1023.
56. Futter C.E., Collinson L.M., Backer J.M., Hopkins C.R. Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J. Cell Biol. 2001, 155:1251-1264.
57. Gadola S.D., Zaccai N.R., Harlos K., Shepherd D., Castro-Palomino J.C., Ritter G., Schmidt R.R., Jones E.Y., Cerundolo V. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat. Immunol. 2002, 3:721-726.
58. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M., Besra G.S., Dwek R., Butters T.D., Platt F.M., Cerundolo V. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J. Exp. Med. 2006, 203:2293-2303.
59. Gilleron M., Stenger S., Mazorra Z., Wittke F., Mariotti S., Bohmer G., Prandi J., Mori L., Puzo G., De Libero G. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 2004, 199:649-659.
60. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: What's in a name?. Nat. Rev. Immunol. 2004, 4:231-237.
61. Goldberg A.L., Rock K.L. Proteolysis, proteasomes and antigen presentation. Nature 1992, 357:375-379.
62. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
63. Gutsmann T., Riekens B., Bruhn H., Wiese A., Seydel U., Leippe M. Interaction of amoebapores and NK-lysin with symmetric phospholipid and asymmetric lipopolysaccharide/phospholipid bilayers. Biochemistry 2003, 42:9804-9812.
64. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 1981, 50:733-764.
65. Harzer K., Paton B.C., Poulos A., Kustermann-Kuhn B., Roggendorf W., Grisar T., Popp M. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses. Eur. J. Pediatr. 1989, 149:31-39.
66. Harzer K., Paton B.C., Christomanou H., Chatelut M., Levade T., Hiraiwa M., O'Brien J.S. Saposins (sap) A and C activate the degradation of galactosylceramide in living cells. FEBS Lett. 1997, 417:270-274.
67. Hawkins C.A., de Alba E., Tjandra N. Solution structure of human saposin C in a detergent environment. J. Mol. Biol. 2005, 346:1381-1392.
68. Herbst R., Marciano-Cabral F., Leippe M. Antimicrobial and pore-forming peptides of free-living and potentially highly pathogenic Naegleria fowleri are released from the same precursor molecule. J. Biol. Chem. 2004, 279:25955-25958.
69. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H., Ley T.J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994, 76:977-987.
70. Hiesberger T., Huttler S., Rohlmann A., Schneider W., Sandhoff K., Herz J. Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J. 1998, 17:4617-4625.
71. Hiraiwa M., Soeda S., Kishimoto Y., O'Brien J.S. Binding and transport of gangliosides by prosaposin. Proc. Natl. Acad. Sci. USA 1992, 89:11254-11258.
72. Hiraiwa M., O'Brien J.S., Kishimoto Y., Galdzicka M., Fluharty A.L., Ginns E.I., Martin B.M. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch. Biochem. Biophys. 1993, 304:110-116.
73. Hiraiwa M., Martin B.M., Kishimoto Y., Conner G.E., Tsuji S., O'Brien J.S. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): Its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys. 1997, 341:17-24.
74. Ho M.W., O'Brien J.S. Gaucher's disease: Deficiency of 'cid' β-glucosidase and reconstitution of enzyme activity in vitro. Proc. Natl. Acad. Sci. USA 1971, 68:2810-2813.
75. Hooghe-Peters E.L., Fowlkes B.J., Hooghe R.J. A new neuronal marker identified by phosphorylcholine-binding myeloma proteins. Nature 1979, 281:376-378.
76. Hornick C.A., Hamilton R.L., Spaziani E., Enders G.H., Havel R.J. Isolation and characterization of multivesicular bodies from rat hepatocytes: An organelle distinct from secretory vesicles of the Golgi apparatus. J. Cell Biol. 1985, 100:1558-1569.
77. Hulkova H., Cervenkova M., Ledvinova J., Tochackova M., Hrebicek M., Poupetova H., Befekadu A., Berna L., Paton B.C., Harzer K., et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum. Mol. Genet. 2001, 10:927-940.
78. Hullin-Matsuda F., Luquain-Costaz C., Bouvier J., Delton-Vandenbroucke I. Bis(monoacylglycero)phosphate, a peculiar phospholipid to control the fate of cholesterol: Implications in pathology. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:313-324.
79. Ichikawa S., Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998, 8:198-202.
80. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R.C., Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 2004, 199:947-957.
81. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37.
82. Kang S.J., Cresswell P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 2002, 277:44838-44844.
83. Kang S.J., Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 2004, 5:175-181.
84. Karlsson K.A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 1989, 58:309-350.
85. Kaspar A.A., Okada S., Kumar J., Poulain F.R., Drouvalakis K.A., Kelekar A., Hanson D.A., Kluck R.M., Hitoshi Y., Johnson D.E., et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 2001, 167:350-356.
86. Kaufmann S.H. Tuberculosis: Back on the immunologists' agenda. Immunity 2006, 24:351-357.
87. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., Yoshikawa H., Nagata S. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006, 443:998-1002.
88. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
89. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434:520-525.
90. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 2006, 7:978-986.
91. Kishimoto Y., Hiraiwa M., O'Brien J.S. Saposins: Structure, function, distribution, and molecular genetics. J. Lipid Res. 1992, 33:1255-1267.
92. Kobayashi T., Stang E., Fang K.S., de Moerloose P., Parton R.G., Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 1998, 392:193-197.
93. Kobayashi T., Beuchat M.H., Chevallier J., Makino A., Mayran N., Escola J.M., Lebrand C., Cosson P., Gruenberg J. Separation and characterization of late endosomal membrane domains. J. Biol. Chem. 2002, 277:32157-32164.
94. Kolter T., Sandhoff K. Principles of lysosomal membrane digestion: Stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 2005, 21:81-103.
95. Kondoh K., Sano A., Kakimoto Y., Matsuda S., Sakanaka M. Distribution of prosaposin-like immunoreactivity in rat brain. J. Comp. Neurol. 1993, 334:590-602.
96. Kretz K.A., Carson G.S., Morimoto S., Kishimoto Y., Fluharty A.L., O'Brien J.S. Characterization of a mutation in a family with saposin B deficiency: A glycosylation site defect. Proc. Natl. Acad. Sci. USA 1990, 87:2541-2544.
97. Lefrancois S., Zeng J., Hassan A.J., Canuel M., Morales C.R. The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin. EMBO J. 2003, 22:6430-6437.
98. Leippe M. Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite. Cell 1995, 83:17-18.
99. Leippe M., Andra J., Muller-Eberhard H.J. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica. Proc. Natl. Acad. Sci. USA 1994, 91:2602-2606.
100. Leippe M., Andra J., Nickel R., Tannich E., Muller-Eberhard H.J. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: Isolation, primary structure, and pore formation in bacterial cytoplasmic membranes. Mol. Microbiol. 1994, 14:895-904.
101. Li S.C., Kihara H., Serizawa S., Li Y.T., Fluharty A.L., Mayes J.S., Shapiro L.J. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. J. Biol. Chem. 1985, 260:1867-1871.
102. Li S.C., Sonnino S., Tettamanti G., Li Y.T. Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids. J. Biol. Chem. 1988, 263:6588-6591.
103. Li C.M., Park J.H., Simonaro C.M., He X., Gordon R.E., Friedman A.H., Ehleiter D., Paris F., Manova K., Hepbildikler S., et al. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics 2002, 79:218-224.
104. Li Y., Thapa P., Hawke D., Kondo Y., Furukawa K., Hsu F.F., Adlercreutz D., Weadge J., Palcic M.M., Wang P.G., et al. Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J. Proteome Res. 2009, 8:2740-2751.
105. Liepinsh E., Andersson M., Ruysschaert J.M., Otting G. Saposin fold revealed by the NMR structure of NK-lysin. Nat. Struct. Biol. 1997, 4:793-795.
106. Locatelli-Hoops S., Remmel N., Klingenstein R., Breiden B., Rossocha M., Schoeniger M., Koenigs C., Saenger W., Sandhoff K. Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: Patient variant Saposin A lacks lipid extraction capacity. J. Biol. Chem. 2006, 281:32451-32460.
107. Lowin B., Beermann F., Schmidt A., Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 1994, 91:11571-11575.
108. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: Fusion and function. Nat. Rev. Mol. Cell Biol. 2007, 8:622-632.
109. Maitre B., Angenieux C., Salamero J., Hanau D., Fricker D., Signorino F., Proamer F., Cazenave J.P., Goud B., Tourne S., et al. Control of the intracellular pathway of CD1e. Traffic 2008, 9:431-445.
110. Matsuda J., Vanier M.T., Saito Y., Tohyama J., Suzuki K. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Hum. Mol. Genet. 2001, 10:1191-1199.
111. Matsuda J., Kido M., Tadano-Aritomi K., Ishizuka I., Tominaga K., Toida K., Takeda E., Suzuki K., Kuroda Y. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum. Mol. Genet. 2004, 13:2709-2723.
112. Matsuda J., Yoneshige A., Suzuki K. The function of sphingolipids in the nervous system: Lessons learnt from mouse models of specific sphingolipid activator protein deficiencies. J. Neurochem. 2007, 103(Suppl 1):32-38.
113. Matsuo H., Chevallier J., Mayran N., Le Blanc I., Ferguson C., Faure J., Blanc N.S., Matile S., Dubochet J., Sadoul R., et al. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 2004, 303:531-534.
114. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
115. Mehl E., Jatzkewitz H. A cerebrosidesulfatase from swine kidney. Hoppe Seylers Z. Physiol. Chem. 1964, 339:260-276.
116. Miteva M., Andersson M., Karshikoff A., Otting G. Molecular electroporation: A unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin. FEBS Lett. 1999, 462:155-158.
117. Mobius W., van Donselaar E., Ohno-Iwashita Y., Shimada Y., Heijnen H.F., Slot J.W., Geuze H.J. Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 2003, 4:222-231.
118. Montoya C.J., Jie H.B., Al-Harthi L., Mulder C., Patino P.J., Rugeles M.T., Krieg A.M., Landay A.L., Wilson S.B. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J. Immunol. 2006, 177:1028-1039.
119. Moody D.B., Guy M.R., Grant E., Cheng T.Y., Brenner M.B., Besra G.S., Porcelli S.A. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J. Exp. Med. 2000, 192:965-976.
120. Moody D.B., Ulrichs T., Muhlecker W., Young D.C., Gurcha S.S., Grant E., Rosat J.P., Brenner M.B., Costello C.E., Besra G.S., et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000, 404:884-888.
121. Moody D.B., Young D.C., Cheng T.Y., Rosat J.P., Roura-Mir C., O'Connor P.B., Zajonc D.M., Walz A., Miller M.J., Levery S.B., et al. T cell activation by lipopeptide antigens. Science 2004, 303:527-531.
122. Moody D.B., Zajonc D.M., Wilson I.A. Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 2005, 5:387-399.
123. Morimoto S., Martin B.M., Yamamoto Y., Kretz K.A., O'Brien J.S., Kishimoto Y. Saposin A: Second cerebrosidase activator protein. Proc. Natl. Acad. Sci. USA 1989, 86:3389-3393.
124. Munford R.S., Sheppard P.O., O'Hara P.J. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 1995, 36:1653-1663.
125. Nagarajan N.A., Kronenberg M. Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 2007, 178:2706-2713.
126. O'Brien J.S., Kishimoto Y. Saposin proteins: Structure, function, and role in human lysosomal storage disorders. FASEB J. 1991, 5:301-308.
127. O'Brien J.S., Kretz K.A., Dewji N., Wenger D.A., Esch F., Fluharty A.L. Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science 1988, 241:1098-1101.
128. O'Brien J.S., Carson G.S., Seo H.C., Hiraiwa M., Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc. Natl. Acad. Sci. USA 1994, 91:9593-9596.
129. O'Brien J.S., Carson G.S., Seo H.C., Hiraiwa M., Weiler S., Tomich J.M., Barranger J.A., Kahn M., Azuma N., Kishimoto Y. Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 1995, 9:681-685.
130. Odorizzi G., Babst M., Emr S.D. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 1998, 95:847-858.
131. Ohshima T., Murray G.J., Swaim W.D., Longenecker G., Quirk J.M., Cardarelli C.O., Sugimoto Y., Pastan I., Gottesman M.M., Brady R.O., et al. alpha-Galactosidase A deficient mice: A model of Fabry disease. Proc. Natl. Acad. Sci. USA 1997, 94:2540-2544.
132. Paget C., Mallevaey T., Speak A.O., Torres D., Fontaine J., Sheehan K.C., Capron M., Ryffel B., Faveeuw C., Leite de Moraes M., et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007, 27:597-609.
133. Park S.H., Benlagha K., Lee D., Balish E., Bendelac A. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur. J. Immunol. 2000, 30:620-625.
134. Pena S.V., Hanson D.A., Carr B.A., Goralski T.J., Krensky A.M. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 1997, 158:2680-2688.
135. Piper R.C., Luzio J.P. Late endosomes: Sorting and partitioning in multivesicular bodies. Traffic 2001, 2:612-621.
136. Plati T., Visigalli I., Capotondo A., Buono M., Naldini L., Cosma M.P., Biffi A. Development and maturation of invariant NKT cells in the presence of lysosomal engulfment. Eur. J. Immunol. 2009, 39:2748-2754.
137. Porcelli S., Brenner M.B., Greenstein J.L., Balk S.P., Terhorst C., Bleicher P.A. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 1989, 341:447-450.
138. Porcelli S., Morita C.T., Brenner M.B. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature 1992, 360:593-597.
139. Porcelli S., Yockey C.E., Brenner M.B., Balk S.P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J. Exp. Med. 1993, 178:1-16.
140. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., Grone H.J. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 2007, 104:5977-5982.
141. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., Natori T., Koezuka Y., Kulkarni A., Kronenberg M. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001, 291:664-667.
142. Qi X., Chu Z. Fusogenic domain and lysines in saposin C. Arch. Biochem. Biophys. 2004, 424:210-218.
143. Raftery M.J., Winau F., Kaufmann S.H., Schaible U.E., Schonrich G. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J. Immunol. 2006, 177:6207-6214.
144. Ravichandran K.S., Lorenz U. Engulfment of apoptotic cells: Signals for a good meal. Nat. Rev. Immunol. 2007, 7:964-974.
145. Remmel N., Locatelli-Hoops S., Breiden B., Schwarzmann G., Sandhoff K. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity. FEBS J. 2007, 274:3405-3420.
146. Rigat B., Wang W., Leung A., Mahuran D.J. Two mechanisms for the recapture of extracellular GM2 activator protein: Evidence for a major secretory form of the protein. Biochemistry 1997, 36:8325-8331.
147. Rorman E.G., Scheinker V., Grabowski G.A. Structure and evolution of the human prosaposin chromosomal gene. Genomics 1992, 13:312-318.
148. Rosat J.P., Grant E.P., Beckman E.M., Dascher C.C., Sieling P.A., Frederique D., Modlin R.L., Porcelli S.A., Furlong S.T., Brenner M.B. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J. Immunol. 1999, 162:366-371.
149. Rossmann M., Schultz-Heienbrok R., Behlke J., Remmel N., Alings C., Sandhoff K., Saenger W., Maier T. Crystal structures of human saposins C andD: Implications for lipid recognition and membrane interactions. Structure 2008, 16:809-817.
150. Roy K.C., Maricic I., Khurana A., Smith T.R., Halder R.C., Kumar V. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells. J. Immunol. 2008, 180:2942-2950.
151. Salio M., Speak A.O., Shepherd D., Polzella P., Illarionov P.A., Veerapen N., Besra G.S., Platt F.M., Cerundolo V. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl. Acad. Sci. USA 2007, 104:20490-20495.
152. Sanchez D.J., Gumperz J.E., Ganem D. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 2005, 115:1369-1378.
153. Sandhoff K., Kolter T. Topology of glycosphingolipid degradation. Trends Cell Biol. 1996, 6:98-103.
154. Sano A., Hineno T., Mizuno T., Kondoh K., Ueno S., Kakimoto Y., Inui K. Sphingolipid hydrolase activator proteins and their precursors. Biochem. Biophys. Res. Commun. 1989, 165:1191-1197.
155. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2:965-975.
156. Schaible U.E., Winau F., Sieling P.A., Fischer K., Collins H.L., Hagens K., Modlin R.L., Brinkmann V., Kaufmann S.H. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 2003, 9:1039-1046.
157. Schlote W., Harzer K., Christomanou H., Paton B.C., Kustermann-Kuhn B., Schmid B., Seeger J., Beudt U., Schuster I., Langenbeck U. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur. J. Pediatr. 1991, 150:584-591.
158. Schnabel D., Schroder M., Sandhoff K. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 1991, 284:57-59.
159. Schroder-Borm H., Bakalova R., Andra J. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett. 2005, 579:6128-6134.
160. Schumann J., Facciotti F., Panza L., Michieletti M., Compostella F., Collmann A., Mori L., De Libero G. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur. J. Immunol. 2007, 37:1431-1441.
161. Sever S. AP-2 makes room for rivals. Dev. Cell 2003, 5:530-532.
162. Shamshiev A., Donda A., Prigozy T.I., Mori L., Chigorno V., Benedict C.A., Kappos L., Sonnino S., Kronenberg M., De Libero G. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 2000, 13:255-264.
163. Shamshiev A., Gober H.J., Donda A., Mazorra Z., Mori L., De Libero G. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 2002, 195:1013-1021.
164. Shepherd J.C., Schumacher T.N., Ashton-Rickardt P.G., Imaeda S., Ploegh H.L., Janeway C.A., Tonegawa S. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993, 74:577-584.
165. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., Bloom B.R., Brenner M.B., Kronenberg M., Brennan P.J., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
166. Sieling P.A., Jullien D., Dahlem M., Tedder T.F., Rea T.H., Modlin R.L., Porcelli S.A. CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity. J. Immunol. 1999, 162:1851-1858.
167. Sieling P.A., Ochoa M.T., Jullien D., Leslie D.S., Sabet S., Rosat J.P., Burdick A.E., Rea T.H., Brenner M.B., Porcelli S.A., et al. Evidence for human CD4+ T cells in the CD1-restricted repertoire: Derivation of mycobacteria-reactive T cells from leprosy lesions. J. Immunol. 2000, 164:4790-4796.
168. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
169. Skold M., Xiong X., Illarionov P.A., Besra G.S., Behar S.M. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J. Immunol. 2005, 175:3584-3593.
170. Spada F.M., Grant E.P., Peters P.J., Sugita M., Melian A., Leslie D.S., Lee H.K., van Donselaar E., Hanson D.A., Krensky A.M., et al. Self-recognition of CD1 by gamma/delta T cells: Implications for innate immunity. J. Exp. Med. 2000, 191:937-948.
171. Speak A.O., Salio M., Neville D.C., Fontaine J., Priestman D.A., Platt N., Heare T., Butters T.D., Dwek R.A., Trottein F., et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 2007, 104:5971-5976.
172. Spiegel R., Bach G., Sury V., Mengistu G., Meidan B., Shalev S., Shneor Y., Mandel H., Zeigler M. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: First report of saposin A deficiency in humans. Mol. Genet. Metab. 2005, 84:160-166.
173. Sriram V., Du W., Gervay-Hague J., Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 2005, 35:1692-1701.
174. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 2002, 20:395-425.
175. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., Sette A., Brenner M.B., Porcelli S.A., Bloom B.R., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687.
176. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., Ganz T., Thoma-Uszynski S., Melian A., Bogdan C., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282:121-125.
177. Sugita M., Grant E.P., van Donselaar E., Hsu V.W., Rogers R.A., Peters P.J., Brenner M.B. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999, 11:743-752.
178. Sugita M., Cao X., Watts G.F., Rogers R.A., Bonifacino J.S., Brenner M.B. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 2002, 16:697-706.
179. Sugita M., Barral D.C., Brenner M.B. Pathways of CD1 and lipid antigen delivery, trafficking, processing, loading, and presentation. Curr. Top. Microbiol. Immunol. 2007, 314:143-164.
180. Sun Y., Witte D.P., Ran H., Zamzow M., Barnes S., Cheng H., Han X., Williams M.T., Skelton M.R., Vorhees C.V., et al. Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice. Hum. Mol. Genet. 2008, 17:2345-2356.
181. Szatmari I., Pap A., Ruhl R., Ma J.X., Illarionov P.A., Besra G.S., Rajnavolgyi E., Dezso B., Nagy L. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 2006, 203:2351-2362.
182. Tatti M., Salvioli R., Ciaffoni F., Pucci P., Andolfo A., Amoresano A., Vaccaro A.M. Structural and membrane-binding properties of saposin D. Eur. J. Biochem. 1999, 263:486-494.
183. Tyznik A.J., Tupin E., Nagarajan N.A., Her M.J., Benedict C.A., Kronenberg M. Cutting edge: The mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 2008, 181:4452-4456.
184. Vaccaro A.M., Tatti M., Ciaffoni F., Salvioli R., Maras B., Barca A. Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes. FEBS Lett. 1993, 336:159-162.
185. Vaccaro A.M., Tatti M., Ciaffoni F., Salvioli R., Serafino A., Barca A. Saposin C induces pH-dependent destabilization and fusion of phosphatidylserine-containing vesicles. FEBS Lett. 1994, 349:181-186.
186. Vaccaro A.M., Ciaffoni F., Tatti M., Salvioli R., Barca A., Tognozzi D., Scerch C. pH-dependent conformational properties of saposins and their interactions with phospholipid membranes. J. Biol. Chem. 1995, 270:30576-30580.
187. van Der Vliet H.J., Nishi N., de Gruijl T.D., von Blomberg B.M., van den Eertwegh A.J., Pinedo H.M., Giaccone G., Scheper R.J. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 2000, 95:2440-2442.
188. Vincent M.S., Leslie D.S., Gumperz J.E., Xiong X., Grant E.P., Brenner M.B. CD1-dependent dendritic cell instruction. Nat. Immunol. 2002, 3:1163-1168.
189. Vyas J.M., Van der Veen A.G., Ploegh H.L. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 2008, 8:607-618.
190. Wang Y., Grabowski G.A., Qi X. Phospholipid vesicle fusion induced by saposin C. Arch. Biochem. Biophys. 2003, 415:43-53.
191. Wenger D.A., DeGala G., Williams C., Taylor H.A., Stevenson R.E., Pruitt J.R., Miller J., Garen P.D., Balentine J.D. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency. Am. J. Med. Genet. 1989, 33:255-265.
192. Wilkening G., Linke T., Uhlhorn-Dierks G., Sandhoff K. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP. J. Biol. Chem. 2000, 275:35814-35819.
193. Winau F., Kaufmann S.H., Schaible U.E. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell. Microbiol. 2004, 6:599-607.
194. Winau F., Schwierzeck V., Hurwitz R., Remmel N., Sieling P.A., Modlin R.L., Porcelli S.A., Brinkmann V., Sugita M., Sandhoff K., et al. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 2004, 5:169-174.
195. Winau F., Hegasy G., Kaufmann S.H., Schaible U.E. No life without death-Apoptosis as prerequisite for T cell activation. Apoptosis 2005, 10:707-715.
196. Winau F., Weber S., Sad S., de Diego J., Hoops S.L., Breiden B., Sandhoff K., Brinkmann V., Kaufmann S.H., Schaible U.E. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006, 24:105-117.
197. Winau F., Hegasy G., Weiskirchen R., Weber S., Cassan C., Sieling P.A., Modlin R.L., Liblau R.S., Gressner A.M., Kaufmann S.H. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007, 26:117-129.
198. Winkelmann J., Leippe M., Bruhn H. A novel saposin-like protein of Entamoeba histolytica with membrane-fusogenic activity. Mol. Biochem. Parasitol. 2006, 147:85-94.
199. Wright C.S., Li S.C., Rastinejad F. Crystal structure of human GM2-activator protein with a novel beta-cup topology. J. Mol. Biol. 2000, 304:411-422.
200. Wright C.S., Zhao Q., Rastinejad F. Structural analysis of lipid complexes of GM2-activator protein. J. Mol. Biol. 2003, 331:951-964.
201. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 1996, 14:369-396.
202. Yuan W., Dasgupta A., Cresswell P. Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat. Immunol. 2006, 7:835-842.
203. Yuan W., Qi X., Tsang P., Kang S.J., Illarionov P.A., Besra G.S., Gumperz J., Cresswell P. Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc. Natl. Acad. Sci. USA 2007, 104:5551-5556.
204. Zhou D., Cantu C., Sagiv Y., Schrantz N., Kulkarni A.B., Qi X., Mahuran D.J., Morales C.R., Grabowski G.A., Benlagha K., et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004, 303:523-527.
205. Zhou D., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.